StockTipsArenaBeta

BUY Shilpa Medicare Limited — Kunal Hasmukhlal Shah

BUYShilpa Medicare Limited
Shilpa Medicare share price target & all analyst calls

byKunal Hasmukhlal ShahHorizon: 1–3 months1 Sept 2026via NDTV Profit

Entry₹877.45Inferred
Target₹950
Total upside +8.27% (call closed)
Stop lossNot given
Exit₹9503 Sept 2026, 12:09 pm
Target hit+8.27%0.00%upside left
Follow Kunal Hasmukhlal Shah for new calls(81% target hit, 16 closed calls)Get alertsWatch SHILPAMED for new buy/sell callsGet alertsSee 45 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 1 Sept 2026
1 supporting4 neutral2 opposing
Supports the BUY call (1)

Shilpa Medicare Q1 Results: Highest quarterly revenue and EBITDA on record sends stock 17% higher

NewsCnbc-Tv18·5 Aug · 4w ago

(opens in new tab)
Neutral / worth noting (4)

Shilpa Medicare recalls 27,923 chemotherapy drug vials in US over discolouration

NewsCnbc-Tv18·18 Aug · 2w ago

(opens in new tab)

Q1 Results Today Highlights: Godrej Agrovet posts mixed Q1; Whirlpool PAT falls 34%, Berger Paints, Biocon, Shilpa Medicare, Aster DM, Navin Fluorine report profit growth

NewsHbl·5 Aug · 4w ago

(opens in new tab)

Shilpa Medicare Limited has submitted to the Exchange, the Unaudited standalone and consolidated financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·5 Aug · 4w ago

(opens in new tab)

Unaudited Financial Results for the Quarter ended 30 June 2026

BSE · Board Meeting·5 Aug · 4w ago

(opens in new tab)
Weighs against the BUY call (2)

Shilpa Medicare Limited Initiates Recall of Pemrydi Rtu (Pemetrexed Injection) Due to Discolored Solution

NewsGoogle News·29 Aug · 3d ago

(opens in new tab)

Shilpa Medicare Recalls Over 27,000 Chemotherapy Vials In US After Discolouration Reports

NewsNdtv-Profit·18 Aug · 2w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Shilpa Medicare

All analyst calls on Shilpa Medicare

More from Kunal Hasmukhlal Shah

Every call and its outcome